A lot has happened in terms of news in the sector, although there is nothing that was thesis changing. There are some new potential trends to watch but at this.
Today is the eye in the center of the storm with a number of earnings tomorrow. It might also be the eye in the center of the North Korean crisis.
The market is surging and is dragging the sector higher with it. It seems to me that the sector is not doing particularly well given the new risk on environment.
Nothing dramatically new happening in the sector. There are a couple of interesting tidbits that are worth talking about but certainly no thesis changing or confirming news. 1. JNJ started.
More of the same as we move into Easter weekend. Tensions are building in Korea and there is almost a pathological disinterest in biotech with anemic volumes. If this were.
We are inching closer to a major black swan as I noted earlier. This is keeping me very cautious about initiating new positions in size. Keep in mind that April.
I promised to talk about more stocks that are on my radar but I am going to change it up a little. I do not like to stray too far.
AACR is in full swing with a couple more days worth of data coming but so far there has not been anything thesis changing to the upside or downside. To.
Yesterday was the opposite of my market thesis but perhaps that was related to the new talk about healthcare reform not being dead. I would slightly increase the odds that.
So an interesting day yesterday in that the sector outperformed the broader market (as I expected) but the broader market was not as weak. Obviously my market headwind/bio tailwind call.
We are back in a macro driven world (at least for the near term). The failure of TrumpCare will have two impacts on the sector. First, the odds of drug.
We finally had a 1%+ down day in the market, so we can finally stop seeing on the tweets about how long it has been since a 1% sell off..
A quick note on ESPR as I somehow missed the FDA news this morning that a couple of you kindly pointed out. This makes the move much more reasonable than.
Well, this is not going to be a good day for the sector and that wall at 300 in the IBB is likely safe for now. The key culprit is.
The sector is on the edge of either breaking down or breaking out. While it is hard to have very strong conviction, I would lean towards a breakout especially given.
The sector has been interesting. Given the past 18 months, it feels easy to be bearish on every pullback consolidation but I am incrementally more positive. It is starting to.
There is a little bit of news to start the week but nothing that likely seems thesis changing or will have a dramatic impact on sentiment/trends. We are in the.